Sublingual buprenorphine/naloxone precipitated withdrawal in subjects maintained on 100mg of daily methadone (Q36170053)

12 August 2017

Sublingual buprenorphine/naloxone precipitated withdrawal in subjects maintained on 100mg of daily methadone (English)

1 reference

12 August 2017

James Rosado

1

1 reference

12 August 2017

Sharon L Walsh

series ordinal

2

1 reference

12 August 2017

George E Bigelow

series ordinal

3

1 reference

12 August 2017

Eric C Strain

series ordinal

4

1 reference

12 August 2017

22 May 2007

1 reference

Drug and Alcohol Dependence

12 August 2017

1 reference

12 August 2017

90

1 reference

12 August 2017

2-3

1 reference

12 August 2017

261-269

1 reference

Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094723

Relative bioavailability of different buprenorphine formulations under chronic dosing conditions

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094723

Clinical efficacy of buprenorphine: comparisons to methadone and placebo

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094723

Pharmacokinetics of the combination tablet of buprenorphine and naloxone

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094723

The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094723

Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094723

Effects of buprenorphine/naloxone in opioid-dependent humans

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094723

Effects of buprenorphine versus buprenorphine/naloxone tablets in non-dependent opioid abusers

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094723

Clinical pharmacology of buprenorphine: ceiling effects at high doses

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094723

Acute effects of buprenorphine, hydromorphone and naloxone in methadone-maintained volunteers

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094723

Methods for evaluating addiction liability. (A) "Attitude" of opiate addicts toward opiate-like drugs. (B) a short-term "direct" addiction test.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094723

Pharmacokinetics and pharmacodynamics of multiple sublingual buprenorphine tablets in dose-escalation trials

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094723

Pharmacokinetics and subjective effects of sublingual buprenorphine, alone or in combination with naloxone: lack of dose proportionality

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094723

Severe opiate withdrawal in a heroin user precipitated by a massive buprenorphine dose.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094723

Buprenorphine and naloxone co-administration in opiate-dependent patients stabilized on sublingual buprenorphine

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094723

Respiratory effects of opioid full and partial agonists in rhesus monkeys.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094723

Effects of buprenorphine and methadone in methadone-maintained subjects.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094723

Effects of sublingually given naloxone in opioid-dependent human volunteers

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094723

Plasma and urine levels of methadone. Comparison following four medication forms used in chronic maintenance treatment

23 September 2018

1 reference

12 December 2020

Plasma levels and symptom complaints in patients maintained on daily dosage of methadone hydrochloride

1 reference

12 December 2020

Precipitated withdrawal by pentazocine in methadone-maintained volunteers

1 reference

12 December 2020

Buprenorphine effects in methadone-maintained volunteers: effects at two hours after methadone

1 reference

12 December 2020

The effects of buprenorphine in buprenorphine-maintained volunteers

1 reference

12 December 2020

High Interindividual Variability of Methadone Enantiomer Blood Levels to Dose Ratios

1 reference

12 December 2020

Effects associated with double-blind omission of buprenorphine/naloxone over a 98-h period

1 reference

12 December 2020

10.1016/J.DRUGALCDEP.2007.04.006

Identifiers

DOI

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

17517480

1 reference